Transient Expression of Genes Delivered to Newborn Rat Liver Using Recombinant AAV2/8 Vectors

被引：0
作者：
Flageul, Maude [1 ]
Aubert, Dominique [1 ]
Pichard, Virginie [1 ]
Nguyen, Tuan Huy [1 ]
Ferry, Nicolas [1 ]
机构：
[1] CHU Hotel Dieu, Lab Biotherapies Hepat, INSERM, U948,EA 4274, F-44035 Nantes 1, France
来源：
HUMAN GENE THERAPY | 2009年 / 20卷 / 06期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
引用
收藏
页码：676 / 677
页数：2
相关论文
共 50 条
  • [21] Sustained correction of OTC deficiency in spfash mice using optimized self-complementary AAV2/8 vectors
    Wang, L.
    Wang, H.
    Morizono, H.
    Bell, P.
    Jones, D.
    Lin, J.
    McMenamin, D.
    Yu, H.
    Batshaw, M. L.
    Wilson, J. M.
    [J]. GENE THERAPY, 2012, 19 (04) : 404 - 410
  • [22] Optimization of transgene expression in the trabecular meshwork (TM) by comparing capsid mutant AAV2 vectors
    Harman, Christine
    Koehl, Kristin
    Oh, Annie
    Chiodo, Vince A.
    Boye, Sanford L.
    Hauswirth, William W.
    Boye, Shannon Elizabeth
    Komaromy, Andras M.
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [23] Site-Directed Mutagenesis of Surface-Exposed Lysine Residues Leads to Improved Transduction by Recombinant AAV2 and AAV8 Vectors in Murine Hepatocytes In Vivo
    Li, Baozheng
    Ma, Wenqin
    Aslanidi, George
    Ling, Chen
    Van Vliet, Kim
    Agbandje-McKenna, Mavis
    Srivastava, Arun
    [J]. MOLECULAR THERAPY, 2013, 21 : S208 - S209
  • [24] AAV2/8 Vectors Purified from Culture Medium with a Simple and Rapid Protocol Transduce Murine Liver, Muscle, and Retina Efficiently
    Doria, Monica
    Ferrara, Antonella
    Auricchio, Alberto
    [J]. HUMAN GENE THERAPY METHODS, 2013, 24 (06) : 392 - 398
  • [25] Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors
    Q Liu
    W Huang
    H Zhang
    Y Wang
    J Zhao
    A Song
    H Xie
    C Zhao
    D Gao
    Y Wang
    [J]. Gene Therapy, 2014, 21 : 732 - 738
  • [26] Neutralizing antibodies against AAV2, AAV5 and AAV8 in healthy and HIV-1-infected subjects in China: implications for gene therapy using AAV vectors
    Liu, Q.
    Huang, W.
    Zhang, H.
    Wang, Y.
    Zhao, J.
    Song, A.
    Xie, H.
    Zhao, C.
    Gao, D.
    Wang, Y.
    [J]. GENE THERAPY, 2014, 21 (08) : 732 - 738
  • [27] A metabolically responsive insulin transgene delivered by AAV2/8 pseudotyped, self-complementary AAV (SC-AAV2/8) controls glycemia in STZ-diabetic mice
    Kozlowski, M
    Lyszcowizc, D
    Campbell, AG
    Olson, DE
    Rubin, JE
    Thule, PM
    [J]. MOLECULAR THERAPY, 2004, 9 : S143 - S144
  • [28] Sustained Therapeutic Reversal of Canine Bestrophinopathy with Gene Therapy using Recombinant AAV2
    Guziewicz, Karina
    Komaromy, Andras
    Iwabe, Simone
    Cideciyan, Artur
    Dutrow, Emily
    Zangerl, Barbara
    Beltran, William
    Jacobson, Samuel
    Hauswirth, William
    Aguirre, Gustavo
    [J]. INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [29] Tyrosine-phosphorylation of AAV2 vectors and its consequences on viral intracellular trafficking and transgene expression
    Zhong, Li
    Li, Baozheng
    Jayandharan, Giridhararao
    Mah, Cathryn S.
    Govindasamy, Lakshmanan
    Agbandje-McKenna, Mavis
    Herzog, Roland W.
    Aken, Kirsten A. Weigel-Van
    Hobbs, Jacqueline A.
    Zolotukhin, Sergei
    Muzyczka, Nicholas
    Srivastava, Arun
    [J]. VIROLOGY, 2008, 381 (02) : 194 - 202
  • [30] Impact of Age at Administration, Lysosomal Storage, and Transgene Regulatory Elements on AAV2/8-Mediated Rat Liver Transduction
    Cotugno, Gabriella
    Annunziata, Patrizia
    Barone, Maria Vittoria
    Karali, Marianthi
    Banfi, Sandro
    Auricchio, Alberto
    [J]. PLOS ONE, 2012, 7 (03):
12345